Lantheus Holdings, Inc (LNTH) — Analysis Summary
Lantheus Holdings, Inc (LNTH) has a market cap of $6.56B with year-over-year revenue growth of +0.5%. Net margin stands at 15.2%. The stock trades at a P/E ratio of 23.8.
Key Takeaways
- Revenue changed +0.5% year-over-year
- Net margin of 15.2%
- P/E ratio of 23.8
Compared to other companies in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector, LNTH posted revenue growth of +0.5% and trades at a P/E of 23.8.
Lantheus Holdings, Inc (LNTH)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
Sector
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Employees
1,193
Headquarters
NORTH BILLERICA, MA
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.